Elevance Health, Inc. (NYSE:ELV) Q2 2024 Earnings Call Transcript July 17, 2024 8:30 AM ET
Company Participants
Steve Tanal - VP of IR
Gail Boudreaux - President and CEO
Mark Kaye - CFO
Felicia Norwood - President, Government Health Benefits
Pete Haytaian - President, Carelon
Morgan Kendrick - President, Commercial Health Benefits
Conference Call Participants
A.J. Rice - UBS
Nathan Rich - Goldman Sachs
Lance Wilkes - Bernstein
Kevin Fischbeck - Bank of America
Josh Raskin - Nephron Research
Lisa Gill - JPMorgan
Justin Lake - Wolfe Research
Erin Wright - Morgan Stanley
Michael Ha - Baird
Andrew Mok - Barclays
Ryan Langston - Cowen
Stephen Baxter - Wells Fargo
Scott Fidel - Stephens
Sarah James - Cantor Fitzgerald
George Hill - Deutsche Bank
Whit Mayo - Leerink Partners
Dave Windley - Jefferies
Ann Hynes - Mizuho Securities
Ben Hendrix - RBC Capital Markets
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session where participants are encouraged to present a single question. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.
Steve Tanal
Good morning, and welcome to Elevance Health's second quarter 2024 earnings call. This is Steve Tanal, Vice President of Investor Relations. And with us this morning on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, our CFO; Pete Haytaian, President of Carelon; Morgan Kendrick, President of our Commercial Health Benefits business; and Felicia Norwood, President of our Government Health Benefits business. Gail will begin the call with a brief discussion of the quarter and recent progress against our strategic initiatives. Mark will then discuss our financial results and outlook in greater detail. After our prepared remarks, the team will be available for Q&A.
During the call, we will reference certain non-GAAP measures. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are available on our website, elevancehealth.com. We will also be making some forward-looking statements on this call. Listeners are cautioned that these statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of Elevance Health. These risks and uncertainties can cause actual results to differ materially from our current expectations. We advise listeners to carefully review the risk factors discussed in today's press release and in our quarterly filings with the SEC.